Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers.
Colon-Otero G, Zanfagnin V, Hou X, Foster NR, Asmus EJ, Wahner Hendrickson A, Jatoi A, Block MS, Langstraat CL, Glaser GE, Dinh TA, Robertson MW, Camoriano JK, Butler KA, Copland JA, Weroha SJ.
Colon-Otero G, et al. Among authors: robertson mw.
ESMO Open. 2020 Oct;5(5):e000926. doi: 10.1136/esmoopen-2020-000926.
ESMO Open. 2020.
PMID: 33109627
Free PMC article.
Clinical Trial.